Compare Nutrien Ltd (NTR) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nutrien Ltd vs Tenet Healthcare Corporation — how do they compare? Nutrien Ltd trades at $80.84 (market cap $38.66B), while Tenet Healthcare Corporation trades at $269.36 (market cap $21.67B). The key difference: Nutrien Ltd is the larger of the two by market cap, and Nutrien Ltd pays a 2.73% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| NTR | THC | |
|---|---|---|
Market Cap | $38.66B | $21.67B |
Sector | Basic Materials | Health |
52-Week High | $83.94 | $280.77 |
52-Week Low | $53.64 | $161.37 |
Enterprise Value | $50.46B | $32.74B |
Dividend Yield | 2.73% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nutrien (NTR) trades at $80.68, up 1.52% today, near the analyst high target of $81.00. The stock shows a bullish technical trend with strong moving averages, though RSI levels indicate overbought conditions. Recent Q2 2026 earnings missed EPS estimates but beat on revenue, driven by higher fertilizer prices. The company maintains a moderate buy consensus with 61% of analysts recommending buys, supported by institutional accumulation like BlackRock's $220.94 million purchase in Q2 2026.
Outlook remains positive due to structural advantages in North American nitrogen assets and long-term agricultural demand, but risks include cyclical earnings, sulfur cost pressures, and volume constraints. The current price above the $76.17 consensus target suggests limited near-term upside, requiring monitoring of Q3 2026 results and cost management.
Tenet Healthcare (THC) trades at $259.06, down 2.26% today, with a bearish technical signal but strong fundamentals. The stock shows robust profitability with an 82.83% gross margin and 53.31% ROE, supported by three consecutive quarterly EPS beats. Recent news includes a $2 billion senior notes offering for refinancing and participation in the Wells Fargo Healthcare Conference, highlighting active capital management and investor engagement.
Outlook remains positive due to undervaluation (P/E 10.4 vs. industry) and a $281.44 consensus price target, though risks include negative net cash flow and high debt. Analyst sentiment is strongly bullish with 81% buy ratings, but technical weakness near support at $256 may signal short-term pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nutrien Ltd
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
